Distinct morphophenotypic features of chronic B‐cell leukaemias identified with CDlc and CD23 antibodies

Abstract: Morphological criteria usually applied to diagnose various subtypes of B‐cell chronic lymphoid leukaemia are largely subjective. Immu‐nophenotyping of 61 relevant cases using a selected panel of monoclonal antibodies (mAb), showed that CDlc and CD23 mAb were able to separate B‐cell chronic lymphocytic leukaemia (B‐CLL) from other chronic B‐cell lymphoproliferative diseases. Lymphocytes of B‐CLL were CDlc‐, CD23+, whereas those of other types of chronic B‐cell leukaemia were CDlc+/‐, CD23‐, and CD38 +/‐. Non‐B‐CLL cases had a significantly higher amount of large peroxidase‐negative (unstained) cells analyzed with an automated blood cell counter (Technicon H6000). This type of volumetric assessment allowed a separation between typical and “atypical” B‐CLL, which otherwise were both CDlc‐, and CD23+. These combinations of phenotypic markers corresponded to well‐defined haematopathologic entities, conventionally diagnosed on peripheral blood (PB) and bone marrow smears, and on histologic sections of lymph nodes and spleen.

[1]  H. Gralnick,et al.  Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. , 1989, Journal of clinical pathology.

[2]  M. Chilosi,et al.  Cell-cell and cell-matrix adhesion structures may influence the growth pattern of chronic lymphoid malignancies. , 1989, Leukemia.

[3]  L. Boumsell,et al.  CD1 expression on B‐CLL lymphocytes , 1989, British journal of haematology.

[4]  C. S. Scott,et al.  Diagnostic differentiation of chronic B‐cell malignancies using monoclonal antibody L161 (CD1c) , 1989, British journal of haematology.

[5]  G. Inghirami,et al.  Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia , 1988 .

[6]  M. Ratain,et al.  Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. , 1988, American journal of clinical pathology.

[7]  G. Pinkus,et al.  Circulating malignant cells in non-Hodgkin's lymphoma: correlation with binding by peanut agglutinin. , 1988, Blood.

[8]  F. Rilke,et al.  CD1c but neither CD1a nor CD1b molecules are expressed on normal, activated, and malignant human B cells: identification of a new B-cell subset. , 1988, Blood.

[9]  D. Mason,et al.  Expression of the interleukin-2 receptor (Tac antigen/CD25) in hematologic neoplasms. , 1988, American journal of clinical pathology.

[10]  J. Cawley,et al.  Heterogeneity of CLL: high CD23 antigen and αIFN receptor expression are features of favourable disease and of cell activation , 1988, British journal of haematology.

[11]  B. Drewinko,et al.  Flow cytochemical patterns of white blood cells in human haematopoietic malignancies: II, CHRONIC LEUKAEMIAS , 1987, British journal of haematology.

[12]  H. Schuurman,et al.  Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology. , 1987, The American journal of pathology.

[13]  J. Melo,et al.  Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. , 1987, Journal of clinical pathology.

[14]  A. Berrebi,et al.  Expression of B cell activation antigens on normal and malignant B cells. , 1987, Leukemia.

[15]  F. Rilke,et al.  Expression of the T1 (CD5, p67) surface antigen in B‐CLL and B‐NHL and its correlation with other B‐cell differentiation markers , 1986, Hematological oncology.

[16]  D. Mason,et al.  APAAP LABELLING OF BLOOD AND BONE-MARROW SAMPLES FOR PHENOTYPING LEUKAEMIA , 1986, The Lancet.

[17]  A. Bousvaros,et al.  Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience. , 1985, The American journal of pathology.

[18]  D. Catovsky,et al.  Normal counterparts of hairy cells and B-prolymphocytes in the peripheral blood. An ultrastructural study with monoclonal antibodies and the immunogold method. , 1985, Leukemia research.

[19]  G. Den Ottolander,et al.  Hairy cell leukemia: its place among the chronic B cell leukemias. , 1984, Seminars in oncology.

[20]  H. Zola,et al.  Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes. , 1981, Journal of immunology.

[21]  S. Lewis,et al.  Cell Volume Studies in B‐Cell Leukaemia , 1980, British journal of haematology.

[22]  National cancer institute sponsored study of classifications of non‐hodgkin's lymphomas. Summary and description of a working formulation for clinical usage , 2022 .